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Pseudomonas aeruginosa (PA) biofilm-associated infections are a common cause of 
morbidity in chronic respiratory disease and represent a therapeutic challenge.  Recently, the 
ability of a novel alginate oligomer (OligoG) to potentiate the effect of antibiotics against 
Gram-negative, multi-drug resistant bacteria and inhibit biofilm formation in vitro has been 
described.  Interaction of OligoG with the cell surface of PA was characterized at the 
nanoscale using atomic force microscopy (AFM), zeta potential measurement (surface 
charge) and sizing measurements (dynamic light scattering).  The ability of OligoG to modify 
motility was studied in motility assays.  AFM demonstrated binding of OligoG to the 
bacterial cell surface, which was irreversible following exposure to hydrodynamic shear 
(5,500 g).  Zeta Potential analysis (pH 5-9, 0.1-0.001 M NaCl) demonstrated binding was 
associated with marked changes in the bacterial surface-charge (-30.9±0.8 mV to -47.0±2.3 
mV; pH 5, 0.01 M NaCl; P<0.001).  Sizing analysis demonstrated alteration of surface 
charge was associated with cell aggregation with a 2-3 fold increase in mean particle size at 
OligoG concentrations >2% (914±284 nm to 2599±472 nm; pH 5, 0.01 M NaCl; P<0.001).  
These changes were associated with marked dose-dependent inhibition in bacterial swarming 
motility in PA and Burkholderia spp.  The ability of OligoG to bind to a bacterial surface, 
modulate surface charge, induce microbial aggregation and inhibit motility, represent 
important direct mechanisms by which antibiotic potentiation and biofilm disruption is 
affected.  These results highlight the value of combining multiple nanoscale technologies to 
further understanding of the mechanisms of action of novel antibacterial therapies. 
 
Keywords: Cystic Fibrosis, Antimicrobial, Biofilm, Atomic Force Microscopy, Zeta 
Potential, Sizing, Pseudomonas aeruginosa, Burkholderia spp. 
Introduction 
Pseudomonas aeruginosa is a versatile opportunistic human pathogen often presenting in a 
range of chronic human diseases with serious clinical implications.  It has a physical/genetic 
“pliability” that enables it to colonise and proliferate in a diverse range of habitats.  P. 
aeruginosa is of particular importance in cystic fibrosis (CF) where it represents the 
dominant, persistent pathogen (1).  The Burkholderia cepacia complex is also important in 
adult CF infections. The establishment of P. aeruginosa biofilms in the lungs results in the 
bacterial cells being encased in extracellular polymeric substance (EPS) and extracellular 
(e)DNA.  These biofilms represent a formidable challenge to conventional antibiotic 
therapies (2) inducing chronic inflammation and, ultimately, reducing lung function (3).  P. 
aeruginosa infection consequently represents a major cause of morbidity and mortality in CF 
patients.  The increasing incidence of multi-drug resistant (MDR) Gram-negative biofilm-
related infections, such as P. aeruginosa, is reflected in an urgent need to identify novel 
antimicrobial therapies. 
Several potential candidate therapies for the treatment of biofilms, derived from the 
marine environment, have recently been described (4−6).  OligoG is a low molecular weight 
antimicrobial agent, derived from the brown seaweed Laminaria hyperborea (7).  We have 
recently demonstrated the ability of OligoG to potentiate the activity of conventional 
antibiotics against MDR bacteria including Pseudomonas, Acinetobacter and Burkholderia 
spp, where OligoG treatment reduced (by up to 512 fold) the minimum inhibitory 
concentrations (MICs) of a range of antibiotics, such as ceftazidime and macrolides, against 
MDR pathogens (5, 8).  Although the mechanism of action is still unclear, in vitro studies 
have demonstrated that these effects are unrelated to membrane permeability, sequestration of 
divalent cations at the cell surface, or inhibition of efflux pumps (in MDR organisms; 5).  
Interestingly, OligoG has also been demonstrated to possess specific anti-biofilm properties; 
reducing the formation of biofilm biomass as revealed by Confocal Laser Scanning (CLSM) 
and Scanning Electron Microscopy (SEM) images (5) and increasing the susceptibility of 
biofilms to physical disruption as measured through rheological and AFM force measurement 
techniques (8).  Physical alteration of the Gram-negative cell-wall was also apparent 
following OligoG treatment, as observed by SEM images (5) but, to date, no characterisation 
of this surface interaction has been performed. 
Previous studies have used a combination of techniques to investigate the mechanisms 
of bacterial adhesion and aggregation to host tissues and biomaterial substrates (9−11).  Zeta 
potential measurements, bacterial motilities and AFM force measurements have all been used 
to determine bacterial attachment to poly(ethylene oxide) brush coatings (10).  However, few 
studies have used a comprehensive combination of techniques to determine the specific 
interactions between antimicrobial agents and their target bacteria. 
Atomic Force Microscopy (AFM) has been previously used to study the nanoscale 
interaction of antimicrobial agents (such as colistin) and antimicrobial peptides, on the 
morphology and topography of the cell surface of MDR, Gram-negative bacteria, including 
P. aeruginosa, Acinetobacter baumannii and Escherichia coli (12-14).  AFM represents a 
valuable characterisation tool to visualise alterations in the cell surface structure following 
exposure to antimicrobial agents. 
In addition to changes in structure, bacterial surface charge is an important determinant 
of a number of key processes in bacterial adhesion and biofilm formation.  Bacterial surface 
charge can be characterized by the zeta potential, which is defined as the electrical potential 
of the interfacial region between the bacterial surface and the aqueous environment (15).  
Electrophoretic Light Scattering (ELS) has become an established tool for zeta potential 
determination in bacteria (16, 17).  Studies on the surface charge of P. aeruginosa strains 
have been performed under various conditions (18, 19).  The net-negative surface charge of 
P. aeruginosa strain PAO1 has been demonstrated in a range of physiological pH’s (pH 4-9), 
which reflects the presence of carboxylate (COO-) groups in the lipopolysaccharide (LPS) of 
the Gram-negative bacterial cell wall (9).  ELS has also been employed to characterise the 
biophysical effects of the antimicrobial peptides BP100 and pepR on the surface charge of E. 
coli (20).   
Dynamic light scattering (DLS) is a technique for the measurement of hydrodynamic 
size, and is another characterisation tool to test the effect of specific agents on bacteria cells.  
DLS has previously been used to demonstrate an increase in bacterial cell size after TiO2 
treatment due to nano TiO2 biosorption (19).  This technique allows measurement of bacterial 
size and bacterial aggregation. 
The motility of Gram negative bacteria is crucial for colonization and is a major factor 
in the spread of infection in vivo.  P. aeruginosa motility has been strongly implicated in its 
virulence (21).  Unusually, P. aeruginosa possess three distinct means of motility which are 
habitat-dependent, namely; flagella-mediated swimming (aqueous motility); type IV pilus 
mediated twitching (solid surface motility); and flagella and type IV pilus mediated swarming 
(semi-solid surface motility) (22).  We have previously shown that OligoG inhibits swarming 
in P. aeruginosa, Proteus mirabilis and E. coli (5). 
Low molecular weight OligoG oligomers have been shown to disrupt biofilm formation 
(8) and modify the structure of mucin (25).  They have an exemplary safety profile (5) and a 
nebulized formulation is currently in Phase II human trials in CF patients at a concentration 
of 6% OligoG (60mg/ml) (EudraCT number 2010-023090-19, www.clinicaltrials.gov 
identifier NCT01465529), however only a fraction of OligoG inhaled is estimated to reach 
the lung.  While the anti-biofilm and antibacterial effects of OligoG offer promising new 
therapy for the treatment of chronic Gram-negative infection in CF, a better understanding of 
the mechanism of action is needed to inform the design and delivery of future 
oligosaccharide-based therapies. 
We sought to characterize the nanoscale interactions of these low MW OligoG 
oligomers with the cell surface of P. aeruginosa using a range of techniques including AFM 
to characterize cell surface and structural changes, ELS to monitor surface charge, and DLS 
to investigate cell size.  The effect of OligoG treatment on cell motility of CF-relevant MDR 
bacteria was also investigated in models of bacterial cell “swarming motility”.  In addition, 
the stability of OligoG binding was studied by exposure of the treated cells to hydrodynamic 
shear.   
 
MATERIALS AND METHODS 
Alginate Oligosaccharide Synthesis  
The OligoG particles used in these experiments were generated from alginate extracted from 
the stem of the brown seaweed Laminaria hyperborea.  OligoG production involved 
purification, fractionation and characterization with NMR of low molecular weight (mean, 
2,600 Mw) oligomers with a high guluronate content (90% to 95%) as previously described 
(5). 
 
Bacteria, Media and Culture Conditions 
Strains used in this study included: P. aeruginosa (PAO1), Burkholderia cenocepacia (LMG 
16656), Burkholderia cepacia (BCC 0001), Burkholderia multivorans (BCC 0011) and 
Staphylococcus aureus (NCTC 6571).  P. aeruginosa (PAO1) was grown at 37˚C for 24 h in 
Mueller-Hinton broth (MH; Oxoid) in shake-flasks at 60 rpm.  One ml of bacterial broth was 
then removed and washed twice at 5,500 g for 3 mins in deionised water to remove any 
growth media.  Bacteria were then incubated in OligoG (0.2-10%) for 20 mins before the 
sample was subjected to further washing and centrifugation at 2,500 g for 6 mins to remove 
excess OligoG.  Then 20 µl of the bacterial suspension was added into 1 ml of the relevant 
electrolytic solution for zeta potential, sizing and AFM analyses.  PAO1 was also grown at 
37˚C for 24 h in the presence of OligoG (10%) in MH broth within shake-flasks at 60 rpm.  
Again, 1 ml of bacterial suspension was removed and subjected to hydrodynamic shear by 
washing in deionised water and centrifugation at 5,500 g (x3) for 3 mins.  The zeta potential, 
sizing and AFM analyses were performed before and after each centrifugation step in pH 5 
and 0.01 M NaCl to determine the effect of hydrodynamic shear (washing) on the interactions 
of OligoG with the PAO1 cells. 
 
Bacterial Motility  
Two methods (a plate and stab assay) were utilised to assess the effect of OligoG on bacterial 
motility (see online supplement for details).  
 
AFM Imaging 
AFM was performed on PAO1 cells grown with/without OligoG (10%) and on cells treated 
with OligoG (0.2-0.5%) after growth in MH (24 h) as described above.  Bacterial suspensions 
(7 µl drops) were dried onto 0.01% poly-L-lysine coated mica plates for imaging.  A 
Dimension 3100 AFM (Bruker) was used to achieve AFM images, using tapping-mode 
operation in air and a scan speed of 0.8 Hz.  AFM images were processedusing Nanoscope 
data-processing software.  
 
Zeta Potential and Sizing Measurements 
Zeta-potential and sizing analyses were performed on PAO1 cells grown with/without 
OligoG (10%) and on cells treated with OligoG (0.2-10%) after growth in MH (24 h) as 
described above.  Bacteria were examined at a range of salt concentrations (0.1-0.001 M 
NaCl) and pHs (5, 7 and 9).  A Zetasizer Nano ZS (Malvern Instruments) and disposable 
capillary cells (DTS1061 Malvern instruments), were used to measure ELS and DLS.  The 
zeta potential of PAO1 was calculated by applying the Smoluchowski’s model (15). 
 
Statistical Analysis 
Minitab (v.14) statistical software was used for all statistical analyses presented.  Group-wise 
comparisons were analysed by the non-parametric Kruskal-Wallis test, followed by the 
Mann-Whitney test to determine significant differences for pairwise comparisons if 
appropriate. A P-value of <0.05 was considered statistically significant. To account for 
multiple testing, the Bonferroni-Holm correction was applied to adjust P-values. 
 
RESULTS 
Effect of OligoG on Cell Motility 
OligoG interactions with the important CF pathogens P. aeruginosa, B. cenocepacia, B. 
cepacia, B. multivorans and also S. aureus, were examined to determine effects on bacterial 
motility in vitro.  OligoG inhibited swarming motility of PAO1 in a dose-dependent manner 
at concentrations between 0.2 and 6% (Figure 1A and 1B). This effect was only evident in the 
presence of OligoG.  Bacteria exposed to OligoG in broth conditions demonstrated a 
diminished motility impairment when subsequently plated onto agar containing no OligoG. 
Treatment with OligoG (6%) also inhibited swarming motility of all the Burkholderia strains 
studied (Figure 1C).  The negative control (S. aureus) indicated no bacterial motility with or 
without OligoG.   
 
Effect of OligoG on Modulation of Surface Charge (Zeta Potential) 
OligoG treatment induced a marked alteration in the surface charge of the bacteria, as 
determined by zeta potential measurements using ELS.  OligoG treatment increased the 
overall negative bacterial surface charge (-30.9±0.8 mV to -47.0±2.3 mV; pH 5, 0.01 M 
NaCl) at all pH values (pH 5–9; P<0.001) and at salt concentrations of 0.001 M and 0.01 M 
NaCl (Figures 2A and 2B respectively).  Comparison of the zeta potential distribution of 
PAO1 cells with OligoG-treated PAO1 cells (Figure 2D), revealed a secondary, more 
negative, zeta-potential peak in the measurements (-57.8±2.7 mV; pH 5, 0.01 M NaCl).  
  
Effect of OligoG on Modulation of Cell Size 
Sizing analysis using DLS showed a 2-3 fold increase in measured size for 10% OligoG-
treated cells (914±284 nm to 2599±472 nm; pH 5, 0.01 M NaCl) at all pH values (pH 5-9; 
P<0.001) and in the two salt concentrations of 0.001 M and 0.01 M NaCl (Figure 3A and 3B 
respectively).  Both zeta potential and sizing analyses demonstrated the strong nature of 
OligoG-cell binding (Figures 2 and 3).   
 
Effect on PAO1 grown in the presence of OligoG 
The strength of the interactions between PAO1 and OligoG was also demonstrated by PAO1 
cells grown in the presence of OligoG (Figure 4).  These cells were subjected to 
hydrodynamic shear by washing in deionised water and centrifugation.  The zeta potential 
values revealed that PAO1 cells grown in OligoG exhibited an overall more negative 
bacterial surface charge which was significant (P<0.005) for each of the three hydrodynamic 
shear tests (washes) when compared to PAO1 alone (30.0±0.9 mV to -33.1±1.1 mV; pH 5, 
0.01 M NaCl, 3rd Test) (Figures 4A and 4B).  The zeta potential distributions revealed that 
the secondary, more negative zeta potential peak remained after application of hydrodynamic 
shear, although the secondary peak size reduced in magnitude after the first test (Figures 4A).  
Increase in the size of PAO1 bacteria when grown in the presence of OligoG (869±74 nm to 
1423±145 nm; pH 5, 0.01 M NaCl, 3rd Test), was evident following the hydrodynamic 
analysis (Tests 1-3; P<0.005) (Figures 4B).  AFM analysis confirmed the results obtained 
from the zeta potential and sizing analyses.  Although the majority of the cell surface 
associated OligoG was removed by the initial exposure to hydrodynamic shear, OligoG 
remained bound to the cell surface, was evident after multiple washing steps and was 
associated with cellular aggregation (Figure 4C).   
 
Effect of reduced OligoG concentrations on Surface Charge and Cell Size 
Zeta potential and sizing analyses was used to examine the effect of reduced, more clinically 
relevant, concentrations of OligoG (0.2% and 2%) on PAO1 cells.  Again, OligoG treatment 
resulted in a increase in the overall negative bacterial surface charge (-31.5±0.6 mV to -
34.4±0.6 mV; pH 5, 0.01 M NaCl, 0.2% OligoG; Figure 5) in both 0.2% and 2% OligoG ; 
(P<0.001).  The effects of 0.2% and 2% OligoG treatment on cell size were less apparent 
(Figures E2); a finding which reflects the lack of aggregation observed in treated PAO1 
bacteria at these concentrations. 
 
Effect of OligoG on Bacterial Cell Morphology 
The direct surface interaction of OligoG with PAO1 was studied using AFM to visualize the 
effect of OligoG on the morphology of the PAO1 cells.  AFM clearly demonstrated the 
binding of OligoG to the cell surface of PAO1 (Figures 6A and 6B).  In comparison to the 
untreated control (Figure 6A), Figure 6B shows OligoG not only binding to the cell wall, but 
demonstrates its interaction with the bacterial flagella.   
 
DISCUSSION 
The study utilised AFM, zeta potential measurements, cell sizing and motility assays to 
investigate the mechanisms by which OligoG modifies the Gram-negative bacterial cell-
surface, structure, charge and function.  OligoG was demonstrated to bind to the surface of 
PAO1 thereby inducing specific changes, including decreased bacterial motility and 
swarming, a more negative cell-surface charge and increased cellular aggregation.  The 
results revealed that OligoG had a similar effect on PAO1 populations, whether it was present 
during or after the growth phase.  In addition, the application of hydrodynamic shear showed 
that this binding was strong, and not readily physically reversible.  
In biofilm infections, bacterial motility and swarming are important pathogenicity-
associated traits.  High cell densities and bacterial swarming are believed to be effective 
strategies by which bacteria evade antimicrobial attack (26).  Whilst Khan et al (5) 
demonstrated that OligoG treatment almost completely inhibited swarming of the normally 
motile E. coli, P. aeruginosa, and P. mirabilis, we have shown in the present study, that this 
effective inhibition of bacterial motility is evident in the important Burkholderia spp. CF 
pathogens.  The inhibition of bacterial motility and swarming observed in these experiments 
may result from both direct (i.e. physical) and indirect mechanisms.  Importantly, the changes 
observed in the stab-assay were not the result of increased physical resistance to cellular 
migration in the substrate, as OligoG decreased the viscosity of the medium.  In support of 
this physical inhibition of bacterial movement, AFM studies showed OligoG binding to the 
flagella (Figure 3B) inducing cellular aggregation of the bacteria.  This may reflect one of the 
direct mechanisms of action for OligoG in the inhibition of bacterial cell motility. 
Indirect mechanisms of action are also important and could include specific changes 
in gene expression induced by OligoG in PAO1.  Although not featured in the present study, 
preliminary expression profiling suggests that pilE is down-regulated in OligoG-treated P. 
aeruginosa (unpublished data), which would indeed support that hypothesis.  The observed 
inhibition of swarming motility with OligoG in the present study may therefore, reflect down-
regulation of the expression of quorum-sensing genes, which are essential for biofilm 
development (27, 28, 29).  Interestingly, Gram-negative bacteria (including P. aeruginosa) 
exhibit elevated resistance to various antibiotics under swarming conditions (21, 30) and the 
reduced motility of MDR Pseudomonas and Burkholderia spp. may be linked to the antibiotic 
potentiation that we have previously described (5, 8).   
Biofilm growth is governed by a number of physical, chemical and biological 
processes.  The initial stages of bacterial adhesion involve the transport of cells to a surface.  
This occurs either by physical interactions, such as hydrodynamic forces, Brownian motion 
or, by bacterial appendages e.g. flagella-mediated locomotion.  Initial (reversible) adhesion is 
governed by “long range forces” including: electrostatic (double-layer) interaction (repulsive 
due to negative charges of the cells and surface), steric interactions, van der Waals forces 
(attractive) and hydrophobic/hydrophilic interactions (31, 32).  Determination of the surface 
charge properties of PAO1 in the presence of OligoG in an aqueous environment may 
facilitate our understanding of potential cell-surface interactions in these early stages of 
biofilm growth.   
In the lung, epithelial surfaces are coated with mucin, which is negatively-charged 
due to the presence of N-acetylneuraminic acid and sulphated sugars (33, 34).  The 
importance of electrostatic charge in surface adhesion has been highlighted by the failure of a 
S. aureus mutant, (with increased negative charge due to the lack of D-alanine esters in its 
teichoic acids) to colonise material surfaces (35, 36).  Interestingly, the CF epithelium has 
also been shown to exhibit a reduced negative charge (37) which may favour microbial 
adherence in the CF lung.  The greater negative charge on P. aeruginosa induced by OligoG, 
may effectively increase electrostatic repulsion between OligoG-treated PAO1 and mucin in 
the CF lung (38), thereby reducing bacterial adherence, and subsequent biofilm formation.   
Alteration of the bacterial surface-charge, was evident following OligoG treatment, 
and may arise from its binding directly to LPS on the bacterial cell outer membrane, thereby 
making the LPS more negatively charged.  Electrostatic interactions play an important role in 
the mechanical stability of biofilms (39−41).  Alterations in electrostatic repulsion between 
negatively-charged moieties within a biofilm (in the presence of a negatively-charged 
bioelectric field) may effectively modulate the resultant mechanical structure and thickness 
(42).  This observed change in charge following OligoG treatment may therefore, in addition 
to mediating alterations in bacterial adhesion, result in the altered structural assembly of 
pseudomonal biofilms. The altered structural assembly of OligoG treated biofilms has been 
previously quantified through AFM force measurements which revealed a significantly lower 
Young’s moduli for OligoG treated biofilms and rheological techniques which revealed a 
observed increase in phase angle which reflected a decreased ability of the OligoG-treated 
biofilm to resist structural rearrangement under stress (8).  Also the altered structural 
assembly of OligoG treated pseudomonal biofilms may explain how OligoG treatment was 
able to reduce the MICs of a range of antibiotics against Gram-negative pathogens (5) and 
also how OligoG was able to potentiate antimicrobial treatment in dental biofilm infection 
(Roberts., 2013). DLS demonstrated clear differences in the size of OligoG-treated PAO1.  
DLS however, assumes Brownian motion of the cells and Pseudomonas spp. are motile.  To 
ensure that the observed increase in cell size did not simply reflect decreased motility, direct 
cell measurements were performed using AFM.  This confirmed that the increase in size was 
due to cellular aggregation following OligoG treatment.   
An important finding was that the observed changes in surface charge and cell 
aggregation in P. aeruginosa were evident whether bacteria were grown in the presence of 
OligoG, or established cultures were exposed to OligoG.  This was unsurprising, as we had 
previously shown effects on Pseudomonas spp. in planktonic minimum inhibitory 
concentration (MIC) assays and SEM studies of OligoG treated, established pseudomonal 
biofilms (5).  Hence, OligoG may have potential application in both preventing biofilm 
development (on host or material surfaces) following debridement and bacterial 
decolonization (43) and also as a treatment for established biofilms.  
The physical, surface-charge and structural effects on P. aeruginosa described here 
may partly explain the observed action of OligoG on bacterial assembly, biofilm formation 
and antibiotic potentiation that have previously been described (5, 8).  The benefits of using a 
combination of nanoscale technologies to characterize interactions between bacteria and 
antibacterial compounds, is also evident from this study.  These findings, together with the 
potentiation of antibiotics against a range of MDR bacteria, and the previously described 
human safety in Phase I chronic inhalation studies, all highlight the potential utility of 
OligoG as an adjunct in the treatment of chronic biofilm-associated lung infections in 
conditions such as CF and chronic obstructive pulmonary disease (COPD).  
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Figure 1.  Effect of OligoG on bacterial motility (A) P. aeruginosa PAO1 cultures grown in 
MH broth with 0, 0.2, 0.5, 2 or 6% OligoG and plated on BM2 agar containing no OligoG. 
(B) PAO1 cultures grown in MH broth without OligoG and plated on BM2 agar containing 0, 
0.2, 0.5, 2 or 6% OligoG. (C) Motility test agar stab cultures supplemented with 0 or 6% 
OligoG, inoculated with S. aureus (NCTC 6571; negative control), B. cenocepacia (LMG 
16656), B. cepacia (BCC 0001), B. multivorans (BCC 0011). 
 
Figure 2. Mean zeta potential values for 10% OligoG, untreated PAO1 or PAO1 treated with 
10% OligoG (post-wash) at various pH values in (A) 0.001 M NaCl and (B) 0.01 M NaCl. 
Typical zeta potential distributions of (C) 10% OligoG and (D) Untreated PAO1 cells only 
(black solid line); PAO1 treated with 10% OligoG (post-wash) (grey solid line).  
 
Figure 3. Cell size analysis of PAO1, PAO1 with 10% OligoG (pre-wash) and PAO1 with 
10% OligoG (post-wash) in (A) 0.001 M NaCl and (B) 0.01 M NaCl.  (C) Typical size 
distribution by volume of OligoG (black solid line), PAO1 (grey solid line) and PAO1 treated 
with 10% OligoG (grey dashed line).  
 
Figure 4. Effect of a hydrodynamic shear test at 5,500 g for 3 mins on OligoG treated cells 
tested in pH 5, 0.01 M NaCl. (A) Typical zeta potential distribution by volume of PAO1 
grown in 10% OligoG after 1st test (black solid line), after 2nd test (grey solid line); after 3rd 
test (grey dashed line). (B) Their corresponding mean zeta potential values (mV) and mean 
sizing values (nm). (C) Corresponding AFM images of PAO1 grown in 10% OligoG after 
each of three hydrodynamic shear tests.  
 
Figure 5. Typical zeta potential distributions at pH 5 and 0.01 M NaCl of (A) Untreated 
PAO1 cells only (black solid line); PAO1 treated with 0.2% OligoG (pre-wash) (grey solid 
line); PAO1 treated with 0.2% OligoG (post-wash) (grey dashed line) and (B) Untreated 
PAO1 cells only (black solid line); PAO1 treated with 2% OligoG (post-wash) (grey line). 
(C) Their corresponding mean zeta potential values (mV). *Not determined as OligoG 
clouded this measurement.  
 
Figure 6. AFM images (4 μm) of (A) untreated P. aeruginosa PAO1 cells and (B) PAO1 
treated with 0.2% OligoG (Z scale of 800 nm). (C) AFM images (7 μm) of PAO1 treated 
with 0.5% OligoG (post-wash) (Z scale of 700 nm).  
 
